Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.
about
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver diseaseHepatopulmonary syndrome: What we know and what we would like to knowPulmonary complications of hepatic diseasesTransjugular intrahepatic portosystemic shunts and portal hypertension-related complicationsPulmonary vascular complications of liver diseasePharmacological treatment for hepatopulmonary syndromeAlveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS)A case report of suspected hepatopulmonary syndrome secondary to ductal plate malformation with chronic active hepatitis in a dog.Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the LiteratureThe Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver DiseaseThe role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndromePulmonary angiogenesis in a rat model of hepatopulmonary syndrome.Schistosomiasis and hepatopulmonary syndrome: the role of concomitant liver cirrhosis.The relationship between hepatopulmonary syndrome and altitude.Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis.Portopulmonary hypertension and hepatopulmonary syndrome.A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans.CT Scan Does Not Differentiate Patients with Hepatopulmonary Syndrome from Other Patients with Liver Disease.Hepatobiliary Quiz (Answers)-16 (2015).Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.Pulmonary manifestations of liver diseases.Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndromeDown-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary CirrhosisThe role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.Pulse oximeter oxygen saturation in prediction of arterial oxygen saturation in liver transplant candidates.Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database.Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.Hepatopulmonary syndrome: update on pathogenesis and clinical features.Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment.Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).Pulmonary complications in chronic liver disease.Therapeutic options in pulmonary hepatic vascular diseases.Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases.Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome.Endothelin-1 activation of the endothelin B receptor modulates pulmonary endothelial CX3CL1 and contributes to pulmonary angiogenesis in experimental hepatopulmonary syndrome.Prolonged Unexplained Hypoxemia as Initial Presentation of Cirrhosis: A Case Report.Identifying the Prognosis Factors in Death after Liver Transplantation via Adaptive LASSO in Iran.
P2860
Q24604623-16F2C1A3-902A-42F8-A935-045F382AAB23Q26739041-85123502-6B0D-4AD0-9C87-03B9A5F6F29EQ26741210-9E5F0D5D-4035-46F4-9715-58098C7F1530Q26860685-6187CF09-8C4F-4745-9B7E-2498E1CB745EQ27021918-AC081862-C4B4-4E3A-A35A-6CBDB692C954Q27028173-0EFB1371-ED62-46EC-AFB0-F9028A3B75A5Q27323988-A9B25A0E-2F4E-4C6B-9AF1-659256C20D17Q27336456-08436A4A-C871-4FC9-99A9-D6974F900BA5Q28073854-74622807-CC2D-4727-85AA-75BC1B689B16Q28086776-F8D20273-6806-48C3-9445-3FF89EF79D30Q28571767-9AE71BD8-6D27-4CEC-A936-6516B0E168CDQ33682848-CB7C1E45-34B7-4945-ABBF-000C456EF88EQ33750334-1751E581-867F-4FE5-8FE7-AF498D2F8F3CQ33810062-57B58777-D28C-4445-B4A1-7F613F04A7CFQ33812059-094207E5-D6C3-4401-AB8E-355AB3EF30E1Q33845479-29F04EF6-AB70-4D91-9B54-84FA235691BAQ34914604-FB593F87-2394-419F-8FAE-12DA9A9A36CFQ35991529-B96088E1-A4B2-4A7C-9AFA-04A70CD06376Q36069111-049C5D6D-1640-40AB-853B-0211F2F30CBEQ36492514-024D07F1-F467-4477-BD3C-47D691BD1E23Q37088364-A6ECCA3F-A547-4A12-8CF6-E374467E2047Q37428317-741FD381-31F3-48EA-937B-6B8FF290969DQ37462103-0A32C34B-88D2-4D60-9B6D-17351324A281Q37529248-2779096D-727F-4313-A7EF-44DD03751045Q37575693-76904B2D-6D89-4A41-8D3E-270E441765E5Q37707439-29F0F76F-7996-4190-B83D-B5CD6977CE1DQ37711002-7DF25F02-983F-44D6-A5F8-F739917635B7Q37723358-34048F5E-6298-4D4F-85C1-4708EE9C7DEBQ37875682-E8B6F528-F742-451E-9CD2-45D39ECABCDDQ37893109-72506215-F2D0-481B-AF3D-BC98780FB2EFQ38023147-753B05D9-6CCA-4E02-96AD-58BA62E4E33AQ38063322-722BA88B-F172-4D73-9EB2-E94047CB4F0EQ38098443-473A8A70-4CD0-4C90-9284-8C68C33F1A3CQ38148735-DA8D8458-7D31-45CE-B952-EFDCF61583B9Q38168941-44A20F67-2DDD-4450-8065-389962BCE673Q38263781-0263BD29-A510-428A-ABE1-3A0142AC31DFQ38343199-5F687C5C-0884-4AF6-855D-22C88A9B754DQ40279217-27A32DBC-A4BB-4593-8ABA-B5FEECE60094Q41029433-2699DB9D-8485-45A4-807D-FD1F5B138611Q41038485-282F0B81-C2EA-4D65-A9F9-4F1C5373BCB1
P2860
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Impact of hepatopulmonary synd ...... n liver transplant candidates.
@ast
Impact of hepatopulmonary synd ...... n liver transplant candidates.
@en
type
label
Impact of hepatopulmonary synd ...... n liver transplant candidates.
@ast
Impact of hepatopulmonary synd ...... n liver transplant candidates.
@en
prefLabel
Impact of hepatopulmonary synd ...... n liver transplant candidates.
@ast
Impact of hepatopulmonary synd ...... n liver transplant candidates.
@en
P2093
P2860
P1433
P1476
Impact of hepatopulmonary synd ...... n liver transplant candidates.
@en
P2093
James F Trotter
Kari E Roberts
Keith Wille
Lisa Forman
Michael B Fallon
Michael J Krowka
Neil Kaplowitz
Pulmonary Vascular Complications of Liver Disease Study Group
Robert S Brown
Steven M Kawut
P2860
P304
P356
10.1053/J.GASTRO.2008.06.038
P407
P577
2008-06-20T00:00:00Z